; (ii) section 505 for pediatric formulations; or (iii) section 527; (B) the question of the eligibility for approval of any application under subsection (b)(2) or (j) of section 505 that omits any other conditions of approval entitled to exclusivity under— (i) clause (iii) or (iv) of section 505(j)(5)(F); (ii) clause (iii) or (iv) of section 505(c)(3)(E); or (iii) section 527; or (C) except as expressly provided in paragraphs (1) and (2), the operation of section 505 or section 527. .